ScholarLens Back to search
1973•PEDIATRICSRequires access

Corticosteroids as Primary Therapeutic Agents in Respiratory Distress Syndrome (RDS)

Philip M. Farrell, Richard D. Zachman

Open publisher page 1 citations

Abstract

The long awaited article by Liggins and Howie1 was received with great enthusiasm. Although one must remain cautiously optimistic, it would appear that for the first time an agent is available which transcends the previous methods of supportive management and provides at least a primary approach to prophylactic therapy for RDS. Their data for steroid-treated infants of 26 to 32 weeks' gestation are impressive statistically and the incidence of RDS in the control group (69.6%) is a credible figure based on current estimates.2

About this research paper

What this paper is about

The long awaited article by Liggins and Howie1 was received with great enthusiasm. Although one must remain cautiously optimistic, it would appear that for the first time an agent is available which transcends the previous methods of supportive management and provides at least a primary approach to prophylactic therapy for RDS. Their data for steroid-treated infants of 26 to 32 weeks' gestation are impressive statistically and the incidence of RDS in the control group (69.6%) is a credible figure based on current estimates.2

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The long awaited article by Liggins and Howie1 was received with great enthusiasm. Although one must remain cautiously optimistic, it would appear that for the first time an agent is available which transcends the previous methods of supportive management and provides at least a primary approach to prophylactic therapy for RDS. Their data for steroid-treated infants of 26 to 32 weeks' gestation are impressive statistically and the incidence of RDS in the control group (69.6%) is a credible figure based on current estimates.2

Key concepts: Medicine, Respiratory distress, Incidence (geometry), Intensive care medicine, Pediatrics, Acute respiratory distress, Distress, Internal medicine

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Corticosteroids as Primary Therapeutic Agents in Respiratory Distress Syndrome (RDS) — Research Paper | ScholarLens